Skip to main content
Premium Trial:

Request an Annual Quote

BioView, Ruby Nanomed Form Circulating Tumor Cell Analysis Partnership

NEW YORK — BioView and Ruby Nanomed said on Thursday that they have partnered on the development of a circulating tumor cell (CTC) analysis technology for clinical use.

Under the terms of the alliance, the companies will integrate BioView's Duet imaging system with Ruby Nanomed's Rubychip microfluidic device for CTC isolation, enabling the automatic classification of cancer cells within the device with the goal of facilitating patient monitoring and stratification. The work is being funded by Spanish nonprofit La Caixa Foundation.

Additional terms were not disclosed.

The companies said that the integrated product will initially be available for research use only with clinical trials aimed at securing regulatory approvals starting in 2022.

In 2014, BioView's Duet system received US Food and Drug Administration clearance for use in detecting rearrangements involving the ALK gene in non-small cell lung cancer samples. Earlier this year, the Israeli company and collaborators at Angle presented data on the integration of Duet with Angle's Parsortix cell-sorting platform.

Braga, Portugal-based Ruby Nanomed was founded in 2018 as a spinout of the International Iberian Nanotechnology Laboratory.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.